232 related articles for article (PubMed ID: 18180147)
1. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities.
Martins M; Dastidar SG; Fanning S; Kristiansen JE; Molnar J; Pagès JM; Schelz Z; Spengler G; Viveiros M; Amaral L
Int J Antimicrob Agents; 2008 Mar; 31(3):198-208. PubMed ID: 18180147
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
Vergidis PI; Falagas ME
Curr Opin Investig Drugs; 2008 Feb; 9(2):176-83. PubMed ID: 18246520
[TBL] [Abstract][Full Text] [Related]
3. The current state of multidrug-resistant gram-negative bacilli in North America.
Nicasio AM; Kuti JL; Nicolau DP
Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
[TBL] [Abstract][Full Text] [Related]
4. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
Lomovskaya O; Bostian KA
Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
[TBL] [Abstract][Full Text] [Related]
5. Bacterial efflux pump inhibitors from natural sources.
Stavri M; Piddock LJ; Gibbons S
J Antimicrob Chemother; 2007 Jun; 59(6):1247-60. PubMed ID: 17145734
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant Gram-negative bacteria in postoperative infections.
Singh AV; Mishra B; Thakur A
J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
[TBL] [Abstract][Full Text] [Related]
7. Reversal of resistance in microorganisms by help of non-antibiotics.
Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
[TBL] [Abstract][Full Text] [Related]
8. Treatment of multiresistant Acinetobacter baumannii infections.
Pachón J; Vila J
Curr Opin Investig Drugs; 2009 Feb; 10(2):150-6. PubMed ID: 19197792
[TBL] [Abstract][Full Text] [Related]
9. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
Lynch AS
Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
[TBL] [Abstract][Full Text] [Related]
10. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
11. Colistin and polymyxin B in critical care.
Michalopoulos A; Falagas ME
Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
Mahamoud A; Chevalier J; Alibert-Franco S; Kern WV; Pagès JM
J Antimicrob Chemother; 2007 Jun; 59(6):1223-9. PubMed ID: 17229832
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
Saeed A; Khatoon H; Ansari FA
Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
[TBL] [Abstract][Full Text] [Related]
15. The role of gram-negative bacteria in healthcare-associated pneumonia.
Restrepo MI; Anzueto A
Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.
Rouveix B
J Antimicrob Chemother; 2007 Jun; 59(6):1208-9. PubMed ID: 17507420
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens.
Saha S; Savage PB; Bal M
J Appl Microbiol; 2008 Sep; 105(3):822-8. PubMed ID: 18452533
[TBL] [Abstract][Full Text] [Related]
18. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
[No Abstract] [Full Text] [Related]
20. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
